Review Article

Development of Cardiovascular Indices of Acute Pain Responding in Infants: A Systematic Review

Table 1

Study characteristics.

StudyCountryGestational agePostnatal ageAcute pain procedureCardiovascular measureStudy designQuality score

Abad et al. [34]15Spain37–42<4 daysVenipunctureMean HRCS; randomized trial17
Altun-Köroğlu et al. [35]25Turkey37–414–8 daysHeel stickMaximum HRCS; double-blind, placebo-controlled trial13
Bilgen et al. [36]34Turkey37–421–9 daysHeel stickHR change (%)CS; randomized trial14
Bucher et al. [37]20 Switzerland37–414 daysHeel stick HR change (bpm)CS; randomized trial14
Campos [38]20 United States37–422 days Heel stickMean HRCS; randomized trial15
Cong et al. [40]28United States28–32<14 daysHeel stick HR increase, HRVCS; randomized cross-over trial17
Cong et al. [39]14United States30–32<9 daysHeel stick Mean HR, HRVCS; randomized cross-over trial17
Craig et al. [24]56Canada25–27, 28–30, 31–33, 34–36, and 37–42<8 daysHeel stickMean HRCS; observational17
de Jesus et al. [41]41Brazil37–41<2 days Heel stickHRVCS; observational15
de Oliveira et al. [42]36Brazil37–41<2 daysHeel stickMaximum HR, HRVCS; observational14
Gormally et al. [43]21Canada37–42 2 days Heel stickMean HR, HRVCS; randomized controlled trial15
Goubet et al. [44]14United States28–324 days, 21 daysHeel stickHR changeC; observational13
Gray et al. [45]15United States37–42<3 daysHeel stick Mean HRCS; randomized controlled trial17
Greenberg [46]21United States37–42<1 dayHeel stickMean HRVCS; randomized trial13
Grunau et al. [25]138Canada≤28, 29–32, and 38–414 monthsImmunizationMean HRC; observational16
Haouari et al. [47]15England37–42 <6 daysHeel stickHR change (%)CS; double-blind, placebo controlled trial15
Jatana et al. [48]25India37–42 <7 days Heel stickHR change (bpm)CS; randomized trial10
Johnston et al. [49]20Canada32–35 <10 daysHeel stickMean HRCS; randomized cross-over trial15
Johnston et al. [50]89Canada27, 324 days, 5 weeksHeel stickMean HRCS; observational15
Kostandy et al. [51]19United States37–42 1 dayHepatitis B vaccinationMean HRCS; randomized controlled trial17
Leite et al. [52]29Brazil 37–42<7 daysHeel stickMean HRCS; randomized clinical trial17
Lindh et al. [55]25Sweden37–424-5 daysHeel stickMean HR, HRVCS; observational11
Lindh et al. [54]28Sweden37–42 3 days Venipuncture Mean HR, HRVCS; randomized, double-blind trial15
Lindh et al. [53]45Sweden37–423 months DPT vaccinationMean HR, HRVCS; randomized, double-blind, controlled trial14
Lucas-Thompson et al. [56]49United States 28–31, 32–343–5 days, 3–5 weeksHeel stickMean HR C; observational17
Oberlander et al. [57]23Canada37–422-3 daysHeel stickMean HR, HRVCS; observational13
Oberlander  et al. [58]22Canada37–422 monthsHeel stickMean HR, HRVC; observational13
Oberlander et al. [59]12Canada24–2827–54 daysHeel stickMean HR, HRVCS; observational11
Ors et al. [60]34Turkey37–42<9 daysHeel stickHR change (%)CS; randomized trial15
Owens and Todt [61]20United States37–42 2 daysHeel stickMean HRCS; observational12
Sajedi et al. [62]32Iran37–42 <1 dayIntramuscular injectionMean HRCS; randomized trial13
Shibata et al. [63]47Japan37–423-4 daysHeel stickMean HRCS; observational14
Singh et al. [27]150India32–34, 35–37, and 37–42<7 daysHeel stickMean HRCS; observational 8
Stevens et al. [65]40Canada32–34<5 days Heel stickMean HRCS; descriptive15
Stevens and Johnston [64]124Canada32–34≤5 daysHeel stickMean HR, maximum HR, and HRVCS; observational17
Taksande et al. [66]80India37–42 <7 daysVenipunctureMean HRCS; observational11
Upadhyay et al. [67]41India37–42<15 daysVenipunctureMean HRCS; randomized, placebo-controlled, double-blind trial16
Uyan et al. [68]21Turkey37–42 <11 daysHeel stick HR change (%), maximum HRCS; randomized controlled trial14
Walden et al. [69]11United States24–26 weeks 21 daysHeel stickMean HR, maximum HRC; quasiexperimental, repeated measures18
Weissman et al. [70]29Israel37–422-3 daysHeel stick HR increase (bpm), HRVCS; randomized trial11
Weissman et al. [71]24Israel 37–42 4–6 daysHeel stick Mean HR, HRVCS; randomized controlled trial10

Note. CS = cross-sectional study, C = cohort study. CS and C quality scores are out of 20 and 21, respectively.
Postnatal age = age at measurement.
Out of 20 or 21 depending on research design.